Scarica l'app Stockscreener
9.12
5.59%
-0.54
Dopo l'orario di chiusura:
8.94
-0.18
-1.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALGS Giù?
Forum
Previsione
Aligos Therapeutics Inc Borsa (ALGS) Ultime notizie
Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue Estimates - MSN
(ALGS) Long Term Investment Analysis - Stock Traders Daily
Aligos Therapeutics Presents Positive Data at APASL 2025 - The Manila Times
Clinical Trial Success: Aligos' Dual Breakthroughs in Liver Disease Show 100% Efficacy - StockTitan
Ten option delistings on March 24th - TipRanks
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter
Learn to Evaluate (ALGS) using the Charts - Stock Traders Daily
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
HC Wainwright Issues Negative Outlook for ALGS Earnings - Defense World
Financial Comparison: Achilles Therapeutics (NASDAQ:ACHL) vs. Aligos Therapeutics (NASDAQ:ALGS) - Defense World
H.C. Wainwright cuts Aligos stock target to $70, maintains Buy By Investing.com - Investing.com Australia
H.C. Wainwright cuts Aligos stock target to $70, maintains Buy - Investing.com India
Aligos Therapeutics (NASDAQ:ALGS) Price Target Lowered to $70.00 at HC Wainwright - Defense World
Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition - TipRanks
Aligos Therapeutics Advances Pipeline Amid Financial Challenges - TipRanks
Aligos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aligos Therapeutics reports fourth-quarter and full-year 2024 results -March 10, 2025 at 10:48 am EDT - Marketscreener.com
ALIGOS THERAPEUTICS Earnings Results: $ALGS Reports Quarterly Earnings - Nasdaq
Aligos Therapeutics reports Q4 EPS ($13.08) vs ($5.50) last year - TipRanks
Aligos Therapeutics, Inc. SEC 10-K Report - TradingView
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Aligos Q4 Earnings: $105M Raise Backs Promising HBV Drug Results - StockTitan
Earnings Scheduled For March 10, 2025 - Benzinga
Aligos Therapeutics (ALGS) to Release Quarterly Earnings on Monday - Defense World
ALIGOS THERAPEUTICS Earnings Preview: Recent $ALGS Insider Trading, Hedge Fund Activity, and More - Nasdaq
How the (ALGS) price action is used to our Advantage - Stock Traders Daily
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Up 23.7% in February - Defense World
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025 - The Manila Times
Will Aligos Therapeutics Q4 Results Reveal Progress in Liver Disease Pipeline? - StockTitan
Reviewing Aligos Therapeutics (NASDAQ:ALGS) & Editas Medicine (NASDAQ:EDIT) - Defense World
(ALGS) Trading Report - Stock Traders Daily
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Significant Decline in Short Interest - MarketBeat
Aligos Therapeutics looks to raise $105 million in private placement - MSN
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Down 13.2% in January - Defense World
Aligos Therapeutics Announces $105 Million Private Placement FinancingAligos Therapeutics, Inc. (NASDAQ: ALGS) recently disclosed a Securities Purchase Agreement engagement entailing a Private Placement offering. The agreement includes the issuan - Defense World
Aligos Therapeutics, Inc. announced that it expects to receive $105.003206 million in funding - Marketscreener.com
Aligos Therapeutics secures $105 million in private placement By Investing.com - Investing.com Canada
Aligos Therapeutics secures $105 million in private placement - MSN
Aligos Therapeutics Secures $105M in Private Placement - TipRanks
Aligos Therapeutics rises after $105 million private placement - TradingView
Aligos Therapeutics announces $105M private placement financing - TipRanks
Aligos Therapeutics Announces $105 Million Private Placement Financing - The Manila Times
Major Funding Alert: Aligos Lands $105M Investment for Game-Changing Hepatitis B Drug Development - StockTitan
Trading (ALGS) With Integrated Risk Controls - Stock Traders Daily
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely - Yahoo Canada Finance
Aligos Therapeutics patents new inhibitors of PD-1, PD-L1 or PD-1/PD-L1 interaction - BioWorld Online
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? - Yahoo Finance
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Short Interest Update - MarketBeat
0.39%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):